REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 70 filers reported holding REGULUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 3.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $203,000 | -26.7% | 123,293 | 0.0% | 0.00% | – |
| Q4 2016 | $277,000 | -33.1% | 123,293 | -1.7% | 0.00% | – |
| Q3 2016 | $414,000 | +14.4% | 125,428 | 0.0% | 0.00% | – |
| Q2 2016 | $362,000 | -42.6% | 125,428 | +37.7% | 0.00% | – |
| Q1 2016 | $631,000 | -20.5% | 91,076 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $794,000 | +25.8% | 91,076 | -5.6% | 0.00% | – |
| Q3 2015 | $631,000 | -40.4% | 96,506 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $1,058,000 | +26.6% | 96,506 | +95.6% | 0.00% | 0.0% |
| Q1 2015 | $836,000 | +22.4% | 49,334 | +15.8% | 0.00% | – |
| Q4 2014 | $683,000 | +116.8% | 42,609 | -7.7% | 0.00% | – |
| Q3 2014 | $315,000 | -18.4% | 46,165 | -3.8% | 0.00% | – |
| Q2 2014 | $386,000 | +9.3% | 47,984 | +22.6% | 0.00% | – |
| Q1 2014 | $353,000 | +22.1% | 39,130 | 0.0% | 0.00% | – |
| Q4 2013 | $289,000 | -21.7% | 39,130 | 0.0% | 0.00% | – |
| Q3 2013 | $369,000 | +4.5% | 39,130 | +8.7% | 0.00% | – |
| Q2 2013 | $353,000 | – | 36,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 327,350 | $2,943,000 | 1.62% |
| HealthCor Management, L.P. | 1,575,000 | $14,207,000 | 0.86% |
| Cormorant Asset Management, LP | 200,000 | $1,804,000 | 0.42% |
| BVF INC/IL | 184,999 | $1,669,000 | 0.26% |
| Verity Asset Management, Inc. | 28,410 | $244,000 | 0.25% |
| Callan Capital, LLC | 80,478 | $726,000 | 0.24% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 225,000 | $2,029,000 | 0.22% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 61,846 | $558,000 | 0.05% |
| LMR Partners LLP | 11,815 | $106,000 | 0.02% |
| Weiss Multi-Strategy Advisers LLC | 70,000 | $631,000 | 0.01% |